5-bromo-3-methylpyridine-2-carbonitrile

We are 5-bromo-3-methylpyridine-2-carbonitrile CAS:156072-86-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  5-bromo-3-methylpyridine-2-carbonitrile
CAS.NO:156072-86-5
Synonyms:   5-bromo-3-methylpyridine-2-carbonitrile
5-bromo-3-methyl-2-pyridinecarbonitrile
5-Bromo-2-cyano-3-methylpyridine
5-bromo-3-methyl-2-cyanopyridine
5-bromo-3-methylpicolinenitrile
5-bromo-2-cyano-3-picoline
 
Molecular Formula:C7H5BrN2
Molecular Weight:197.03200
 
Physical and Chemical Properties:
Density:1.61 g/cm3
Boiling point:283.6ºC at 760 mmHg
Melting point:/
Flash point:125.3ºC
Index of Refraction:1.594
 
Specification:
Appearance:Yellow liquid
Purity:≥99.0%
 
Packing:25kg/drum, can also be packaged according to customer requirements
Storage:Preserve in well-closed, light-resistant and airtight containers
Application: Pesticide intermediates, dye intermediates, flavor and fragrance intermediates, pharmaceutical intermediates

5-bromo-3-methylpyridine-2-carbonitrile


Related News: With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. near161308-40-3 Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections.10-bromo-2-fenil-9- (4-fenilfenil) antraceno CAS:1195975-03-1 “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.2-butan-2-yl-3-methoxypyrazine Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.

Related Products
Product Name
methyl 2-bromopentanoate View Details
2-Methoxy-4-nitroaniline View Details
3-Boronobenzoic acid View Details
3-Amino-5-bromo-2-chloropyridine manufacturer Methyl coumalate manufacturer TRIS(2-CHLOROETHYL) PHOSPHATE (TCEP) manufacturer Ethyl dibromofluoroacetate Cas:565-53-7 manufacturer 2-[(3-methyl-4-nitropyridin-2-yl)methylsulfanyl]-1H-benzimidazole manufacturer